Image

Global Vitreoretinal Disorders Market – Industry Trends and Forecast to 2029

Pharmaceutical

Image

Global Vitreoretinal Disorders Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Sep 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Vitreoretinal Disorders Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 1.60 USD Billion
Diagram Market Size (Forecast Year) USD 2.96 USD Billion
Diagram CAGR %

Major Markets Players

  • Aerie Pharmaceuticals
  • Allergan
  • Bausch Health
  • Merck & Co
  • Pfizer

Global Vitreoretinal Disorders Market , By Type (Retinal Tear, Retinal Detachment, Diabetic Retinopathy, Macular Degeneration, Macular Hole, Others), Diagnosis (Digital fluorescein Angiography, Optical Coherence Tomography, Heidelberg Retinal Tomography, Indocyanine Green Angiography, Others), Treatment (Surgery, Medication, Others), Route of Administration (Oral, Parenteral, Ocular, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Vitreoretinal Disorders Market

Vitreoretinal Disorders Market Analysis and Size

The global vitreoretinal disorders market is expected to witness significant growth during the forecast period. Growing cases of diabetes and eye disorders drives the vitreoretinal disorders market. Due to environmental pollution, family history for ophthalmic diseases and adoption of unhealthy lifestyle also boost the growth of the vitreoretinal disorders market. COVID-19 also had a major impact on the market growth.

 Data Bridge Market Research analyses a growth rate in the global vitreoretinal disorders market in the forecast period 2022-2029. The expected CAGR of global vitreoretinal disorders market is tend to be around 8% in the mentioned forecast period. The market was valued at USD 1.6 billion in 2021, and it would grow upto USD 2.96 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Vitreoretinal disorders affect the major structure of the eye, including retina, macula and vitreous fluid. Retina is the light-sensitive layer present back side of the eye that helps focus images and transmit information to the optic nerves. Vitreous is the gel like fluid fill space between the lens and retina. The degeneration of the both retinal cells and vitreous fluid causes vitreoretinal disorders. Symptoms of vitreoretinal disorders includes painless unilateral floaters and/or visual loss, myopia, cataract and others.

Vitreoretinal Disorders Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Retinal Tear, Retinal Detachment, Diabetic Retinopathy, Macular Degeneration, Macular Hole, Others), Diagnosis (Digital fluorescein Angiography, Optical Coherence Tomography, Heidelberg Retinal Tomography, Indocyanine Green Angiography, Others), Treatment (Surgery, Medication, Others), Route of Administration (Oral, Parenteral, Ocular, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Aerie Pharmaceuticals, Inc. (U.S.), Allergan (Ireland), Bausch Health (U.S.), Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Amorphex Therapeutics Holdings, Inc (U.S.), Alcon (Switzerland), Astellas Pharma Inc. (Japan), Bayer AG (Germany), Novartis AG (Switzerland), AstraZeneca (U.K.), Amgen Inc. (U.S.), Carl Zeiss Meditec AG (Germany), HumanOptics Holding AG (Germany), STAAR SURGICAL (U.S.)

Market Opportunities

  • Rising Government Initiatives
  • Increasing Demand for Retail Pharmacies

Global Vitreoretinal Disorders Market Dynamics

Drivers

  • Increase in Elderly Population

The global vitreoretinal disorders market is expected to witness a heavy growth rate in the forecast period driven by the factor of an aging population. The increasing demand in the global cataract market is a replication of growing elderly population, as people aged over 60 years frequently develop conditions in which eyes have reduced elasticity and in turn it affects the normal functioning. This boost the market growth.

  • Increased Strategic Measures and Clinical Research

Rising strategies such as new product launches could help the major market players gain a competitive edge over the other players. For instance, DORC received approval from Health Canada in January 2021 for the application of TissueBlue 0.025%. It would serve as an alternative for indocyanine green and other straining agents. This boosts the market growth

Opportunities

  • Rising Government Initiatives

The growing adoption of initiatives, policies, and programs by the government authorities and many public organizations is improving the access to affordable vision care and this is anticipated to drive the market size. For instance, the International Agency for the Prevention of Blindness launched VISION 2020 with the aim to accelerate the prevention of blindness activities. The program included the World Sight Day which is an initiative that helps in the promotion of rising awareness associated with blindness and vision impairment.

  • Increasing Demand for Retail Pharmacies

Rise in the number of vitreoretinal disorders therapeutics being delivered through retail pharmacies and surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

  • Lack of skilled professionals

The lack of qualified personnel who are unable to treat the patients with appropriate treatments could curb the growth of the global vitreoretinal disorders market over a forecast period.

  • High Cost

The huge expenditure associated with the treatment of vitreoretinal disorders surely hamper the market growth.

This global vitreoretinal disorders market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global vitreoretinal disorders market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Vitreoretinal Disorders Market           

The Covid-19 pandemic greatly affected the market due to reduction in number of patient visits in hospitals and clinics for vitreoretinal disorders and interruption of numerous alternative procedures and outpatient visits. Although, the market is expected to recover with continuation of activities across various domains and approval and administration of Covid-19 vaccines.

Global Vitreoretinal Disorders Market Scope

The global vitreoretinal disorders market is segmented on the basis of type, diagnosis, treatment, distribution channel, route of administration and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Retinal Tear
  • Retinal Detachment
  • Diabetic Retinopathy
  • Macular Degeneration
  • Macular Hole
  • Others

Diagnosis

  • Digital fluorescein Angiography
  • Optical Coherence Tomography
  • Heidelberg Retinal Tomography
  • Indocyanine Green Angiography
  •  Others

Treatment

  • Surgery
  • Medication
  • Others

Route of Administration

  • Oral
  • Parenteral
  • Ocular
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Global Vitreoretinal Disorders Market Regional Analysis/Insights

The global vitreoretinal disorders market is analysed and market size insights and trends are provided by type, diagnosis, treatment, distribution channel, route of administration and end-user as referenced above.

The major countries covered in the global vitreoretinal disorders market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for global vitreoretinal disorders market throughout the forecasted period due to increased government awareness programs, rising population of affluent patients and number of generic drugs.

North America dominates the market due to the improved medical reimbursement structure, high research and development and healthcare expenditure and skilled professionals.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Vitreoretinal Disorders Market Share Analysis

The global vitreoretinal disorders market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global vitreoretinal disorders market.

Key players operating in the global vitreoretinal disorders market include:

  • Aerie Pharmaceuticals, Inc. (U.S.)
  • Allergan (Ireland)
  • Bausch Health (U.S.)
  • Merck & Co. Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Alcon (Switzerland)
  • Astellas Pharma Inc. (Japan)
  • Bayer AG (Germany)
  • Novartis AG (Switzerland)
  • AstraZeneca (U.K.)
  • Amgen Inc. (U.S.)
  • Carl Zeiss Meditec AG (Germany)
  • HumanOptics Holding AG (Germany)
  • STAAR SURGICAL (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The global vitreoretinal disorders market is projected USD 2.96 billion by 2029.
The global vitreoretinal disorders market is projected to grow at a CAGR of 8% during the forecast period of 2022-2029.
Type (Retinal Tear, Retinal Detachment, Diabetic Retinopathy, Macular Degeneration, Macular Hole, Others), Diagnosis (Digital fluorescein Angiography, Optical Coherence Tomography, Heidelberg Retinal Tomography, Indocyanine Green Angiography, Others), Treatment (Surgery, Medication, Others), Route of Administration (Oral, Parenteral, Ocular, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) are covered in this report.
The major players operating in the market are Aerie Pharmaceuticals, Inc. (U.S.), Allergan (Ireland), Bausch Health (U.S.), Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Amorphex Therapeutics Holdings, Inc (U.S.), Alcon (Switzerland), Astellas Pharma Inc. (Japan), Bayer AG (Germany), Novartis AG (Switzerland), AstraZeneca (U.K.), Amgen Inc. (U.S.), Carl Zeiss Meditec AG (Germany), HumanOptics Holding AG (Germany), STAAR SURGICAL (U.S.).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials